GSK-Partnered Alector Hit By Renewed Dementia Skepticism

Doubts About Biomarker

 
• By Andrew McConaghie
  
Brain research
New investment is flooding into neuroscience, but understanding of disease mechanisms still lags far behind areas such as oncology and cardiovascular disease

More from Business

More from Scrip